当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Advances in Drug Delivery Systems from Nanotechnology to Targeted Therapies

Manish Kumar

Recent advancements in drug delivery systems have revolutionized the field of medicine by enhancing the effectiveness and precision of therapeutic interventions. Nanotechnology has emerged as a key player in this paradigm shift, offering innovative strategies to improve drug delivery, bioavailability, and targeting. This review highlights the progress made in drug delivery systems, focusing on the integration of nanotechnology and targeted therapies. The utilization of nanoparticles, liposomes, micelles, and other nanoscale carriers has enabled controlled and sustained release of drugs, minimizing side effects and maximizing therapeutic outcomes. Moreover, the development of targeted therapies has further refined treatment approaches, allowing for personalized medicine and reduced off-target effects. Key challenges and future prospects in the field are also discussed, emphasizing the need for continued research and collaboration to unlock the full potential of these advancements and ultimately improve patient care.